Tipranavir

ARV U.S. Brand Name

Aptivus

ARV Abbreviation(s)

TPV

U.S. FDA Label

Tipranavir Labeling (Package Insert)

ARV Class

Protease Inhibitors

First U.S. Approval

June 22, 2005

U.S. Manufacturer

Boehringer Ingelheim

Formulations

Strength	Formulation	Image	Description	Boosted
250-mg capsules 100-mg/mL oral solution	Capsules Oral Solution	X	oval red pill with TPV imprint	No

Generic Available?

No

Assistance Programs

Displaying 1 - 1 of 1

	Interaction Color Code	Clinical Bottom Line	Clinical Effects	Drug 1 effect	Drug 2 dose	Drug 2 effect	Management
Tipranavir

Subscribe to Tipranavir